--------------------
文献抄録 A phase Ⅱ trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma/Phase Ⅱ multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
壽美田 一貴
1
1東京医科歯科大学脳神経機能外科
pp.989
発行日 2016年11月10日
Published Date 2016/11/10
DOI https://doi.org/10.11477/mf.1436203413
- フリーアクセス
- 1ページ目
Copyright © 2016, Igaku-Shoin Ltd. All rights reserved.